ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Residual tumor volume and survival after CCNU/TMZ in GBM"
Episode Synopsis
Dr. Iyad Alnahhas interviews Drs. Thomas Zeyen and Johannes Weller about their recent manuscript entitled: "Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ", published online in Neuro-Oncology in October 2024.
More episodes of the podcast Neuro-Oncology: The Podcast
A transcriptomic atlas of CNS tumors
11/07/2025
Gut microbiome in primary CNS lymphoma
27/06/2025
Germline analysis of diffuse midline glioma
08/06/2025
Radio-Pathomic maps and MR perfusion
18/04/2025
CSF proteomics in glioma
21/03/2025
Vorasidenib in IDH mutant glioma
08/03/2025
In God we trust